{"title":"细小病毒B19和输血","authors":"Rania M Saleh","doi":"10.15406/htij.2023.11.00299","DOIUrl":null,"url":null,"abstract":"Parvovirus B19 is a common human pathogen that is responsible for a wide range of clinical manifestations, including erythema infectiosum (fifth disease), arthropathy, and fetal hydrops. Infection with Parvovirus B19 can cause significant morbidity in certain patient populations, including pregnant women and individuals with underlying hematologic or immune disorders. This review highlights the importance of screening of Parvovirus B19 infection, particularly in high-risk populations.","PeriodicalId":103294,"journal":{"name":"Hematology & Transfusion International Journal","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Parvovirus B19 and blood transfusion\",\"authors\":\"Rania M Saleh\",\"doi\":\"10.15406/htij.2023.11.00299\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Parvovirus B19 is a common human pathogen that is responsible for a wide range of clinical manifestations, including erythema infectiosum (fifth disease), arthropathy, and fetal hydrops. Infection with Parvovirus B19 can cause significant morbidity in certain patient populations, including pregnant women and individuals with underlying hematologic or immune disorders. This review highlights the importance of screening of Parvovirus B19 infection, particularly in high-risk populations.\",\"PeriodicalId\":103294,\"journal\":{\"name\":\"Hematology & Transfusion International Journal\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-04-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hematology & Transfusion International Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15406/htij.2023.11.00299\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematology & Transfusion International Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/htij.2023.11.00299","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Parvovirus B19 is a common human pathogen that is responsible for a wide range of clinical manifestations, including erythema infectiosum (fifth disease), arthropathy, and fetal hydrops. Infection with Parvovirus B19 can cause significant morbidity in certain patient populations, including pregnant women and individuals with underlying hematologic or immune disorders. This review highlights the importance of screening of Parvovirus B19 infection, particularly in high-risk populations.